Validation of a modified lung graded prognostic assessment as a tool for survival in NSCLC patients with brain metastases

被引:0
|
作者
Xie, M. [1 ]
Zhang, J. [1 ]
Li, X. [1 ]
You, Y. [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Resp Med, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
461P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases
    Subbiah, Ishwaria M.
    Lei, Xiudong
    Weinberg, Jeffrey S.
    Sulman, Erik P.
    Chavez-MacGregor, Mariana
    Tripathy, Debu
    Gupta, Rohan
    Varma, Ankur
    Chouhan, Jay
    Guevarra, Richard P.
    Valero, Vicente
    Gilbert, Mark R.
    Gonzalez-Angulo, Ana M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (20) : 2239 - U24
  • [2] Validation and comparison of breast graded prognostic assessment score and modified breast graded prognostic assessment in patients with brain metastases as prognostic tool
    Fabregat-Franco, Carles
    Stradella, Agostina
    Navarro, Valentin
    Linares, Jennifer
    Recalde Penabad, Sabela
    Velasco Fargas, Roser
    Simo Parra, Marta
    Fernandez Ortega, Adela
    Vethencourt, Andrea
    Falo Zamora, Catalina
    Vazquez Fernandez, Silvia
    Villanueva Vazquez, Rafael
    Galdeano, Manuel
    Gil-Gil, Miguel
    CANCER RESEARCH, 2020, 80 (04)
  • [3] Validation of the Graded Prognostic Assessment for Patients with Lung Cancer and Brain Metastases
    Hong, S. W.
    Song, C.
    Jeon, W.
    Kim, J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S814 - S815
  • [4] A validation study of graded prognostic assessment index for lung cancer patients with brain metastases
    Du, Lingling
    Venur, Vyshak Alva
    Dahiya, Saurabh
    Garje, Rohan
    Osei-Boateng, Kwabena
    Elson, Paul
    Suh, John H.
    Chao, Samuel T.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Validation of the graded prognostic assessment index for patients with brain metastases
    Nieder, Carsten
    Marienhagen, Kirsten
    Geinitz, Hans
    Molls, Michael
    ACTA ONCOLOGICA, 2009, 48 (03) : 457 - 459
  • [6] External validation of modified breast graded prognostic assessment for breast cancer patients with brain metastases
    Griguolo, G.
    Jacot, W.
    Kantelhardt, E.
    Dieci, M. V.
    Bourgier, C.
    Thomssen, C.
    Bailleux, C.
    Miglietta, F.
    Braccini, A. L.
    Conte, P. F.
    Ferrero, J-M.
    Guarneri, V.
    Darlix, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment
    Sperduto, Christina Maria
    Watanabe, Yoichi
    Mullan, John
    Hood, Terry
    Dyste, Gregg
    Watts, Charles
    Bender, Gail Papermaster
    Sperduto, Paul
    JOURNAL OF NEUROSURGERY, 2008, 109 : 87 - 89
  • [8] External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
    Nieder, Carsten
    Popp, Ilinca
    Hintz, Mandy
    Grosu, Anca Ligia
    CURRENT ONCOLOGY, 2022, 29 (10) : 7181 - 7188
  • [9] Validation of the Graded Prognostic Assessment Index for Surgically Treated Patients with Brain Metastases
    Nieder, Carsten
    Geinitz, Hans
    Molls, Michael
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3015 - 3017
  • [10] Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool
    Sperduto, Paul W.
    Deegan, Brian J.
    Li, Jing
    Jethwa, Krishan R.
    Brown, Paul D.
    Lockney, Natalie
    Beal, Kathryn
    Rana, Nitesh G.
    Attia, Albert
    Tseng, Chia-Lin
    Sahgal, Arjun
    Shanley, Ryan
    Sperduto, William A.
    Lou, Emil
    Zahra, Amir
    Buatti, John M.
    Yu, James B.
    Chiang, Veronica
    Molitoris, Jason K.
    Masucci, Laura
    Roberge, David
    Shi, Diana D.
    Shih, Helen A.
    Olson, Adam
    Kirkpatrick, John P.
    Braunstein, Steve
    Sneed, Penny
    Mehta, Minesh P.
    NEURO-ONCOLOGY, 2018, 20 (12) : 1652 - 1660